2024 Q1 Form 10-Q Financial Statement
#000121390024057245 Filed on June 28, 2024
Income Statement
Concept | 2024 Q1 |
---|---|
Revenue | $7.000K |
YoY Change | -46.15% |
Cost Of Revenue | |
YoY Change | |
Gross Profit | |
YoY Change | |
Gross Profit Margin | |
Selling, General & Admin | $988.0K |
YoY Change | -84.4% |
% of Gross Profit | |
Research & Development | $165.0K |
YoY Change | -46.6% |
% of Gross Profit | |
Depreciation & Amortization | $260.0K |
YoY Change | -72.01% |
% of Gross Profit | |
Operating Expenses | $1.186M |
YoY Change | -83.98% |
Operating Profit | -$1.179M |
YoY Change | -84.05% |
Interest Expense | $42.00K |
YoY Change | -81.33% |
% of Operating Profit | |
Other Income/Expense, Net | -$325.0K |
YoY Change | -115.62% |
Pretax Income | -$1.504M |
YoY Change | -80.31% |
Income Tax | |
% Of Pretax Income | |
Net Earnings | -$1.504M |
YoY Change | -80.31% |
Net Earnings / Revenue | -21485.71% |
Basic Earnings Per Share | |
Diluted Earnings Per Share | -$0.24 |
COMMON SHARES | |
Basic Shares Outstanding | 8.946M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2024 Q1 |
---|---|
SHORT-TERM ASSETS | |
Cash & Short-Term Investments | $3.000K |
YoY Change | -99.86% |
Cash & Equivalents | $3.000K |
Short-Term Investments | |
Other Short-Term Assets | $104.0K |
YoY Change | -2.8% |
Inventory | |
Prepaid Expenses | |
Receivables | |
Other Receivables | |
Total Short-Term Assets | $262.0K |
YoY Change | -95.83% |
LONG-TERM ASSETS | |
Property, Plant & Equipment | |
YoY Change | |
Goodwill | |
YoY Change | |
Intangibles | $2.621M |
YoY Change | 40.69% |
Long-Term Investments | |
YoY Change | |
Other Assets | $111.0K |
YoY Change | -93.58% |
Total Long-Term Assets | $2.732M |
YoY Change | -24.05% |
TOTAL ASSETS | |
Total Short-Term Assets | $262.0K |
Total Long-Term Assets | $2.732M |
Total Assets | $2.994M |
YoY Change | -69.67% |
SHORT-TERM LIABILITIES | |
YoY Change | |
Accounts Payable | $4.988M |
YoY Change | 67.55% |
Accrued Expenses | $1.815M |
YoY Change | 49.75% |
Deferred Revenue | |
YoY Change | |
Short-Term Debt | $386.0K |
YoY Change | |
Long-Term Debt Due | $4.461M |
YoY Change | 32.37% |
Total Short-Term Liabilities | $17.07M |
YoY Change | 98.86% |
LONG-TERM LIABILITIES | |
Long-Term Debt | $0.00 |
YoY Change | |
Other Long-Term Liabilities | $859.0K |
YoY Change | -34.92% |
Total Long-Term Liabilities | $859.0K |
YoY Change | -34.92% |
TOTAL LIABILITIES | |
Total Short-Term Liabilities | $17.07M |
Total Long-Term Liabilities | $859.0K |
Total Liabilities | $17.93M |
YoY Change | 81.07% |
SHAREHOLDERS EQUITY | |
Retained Earnings | -$179.2M |
YoY Change | 15.72% |
Common Stock | $1.000K |
YoY Change | |
Preferred Stock | |
YoY Change | |
Treasury Stock (at cost) | |
YoY Change | |
Treasury Stock Shares | |
Shareholders Equity | -$14.94M |
YoY Change | |
Total Liabilities & Shareholders Equity | $2.994M |
YoY Change | -69.67% |
Cashflow Statement
Concept | 2024 Q1 |
---|---|
OPERATING ACTIVITIES | |
Net Income | -$1.504M |
YoY Change | -80.31% |
Depreciation, Depletion And Amortization | $260.0K |
YoY Change | -72.01% |
Cash From Operating Activities | $1.716M |
YoY Change | -151.07% |
INVESTING ACTIVITIES | |
Capital Expenditures | $2.122M |
YoY Change | |
Acquisitions | |
YoY Change | |
Other Investing Activities | |
YoY Change | |
Cash From Investing Activities | -$2.122M |
YoY Change | |
FINANCING ACTIVITIES | |
Cash Dividend Paid | |
YoY Change | |
Common Stock Issuance & Retirement, Net | |
YoY Change | |
Debt Paid & Issued, Net | |
YoY Change | |
Cash From Financing Activities | $371.0K |
YoY Change | |
NET CHANGE | |
Cash From Operating Activities | $1.716M |
Cash From Investing Activities | -$2.122M |
Cash From Financing Activities | $371.0K |
Net Change In Cash | -$35.00K |
YoY Change | -98.96% |
FREE CASH FLOW | |
Cash From Operating Activities | $1.716M |
Capital Expenditures | $2.122M |
Free Cash Flow | -$406.0K |
YoY Change | -87.92% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2024Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2024Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2024Q1 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2024Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-03-31 | |
CY2024Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2024 | |
CY2024Q1 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2024Q1 | dei |
Entity File Number
EntityFileNumber
|
001-39783 | |
CY2024Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
FOXO TECHNOLOGIES INC | |
CY2024Q1 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2024Q1 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
85-1050265 | |
CY2024Q1 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
729 N. Washington Ave. | |
CY2024Q1 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 600 | |
CY2024Q1 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Minneapolis | |
CY2024Q1 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
MN | |
CY2024Q1 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
55401 | |
CY2024Q1 | dei |
City Area Code
CityAreaCode
|
(612) | |
CY2024Q1 | dei |
Local Phone Number
LocalPhoneNumber
|
562-9447 | |
CY2024Q1 | dei |
Security12b Title
Security12bTitle
|
Class A Common Stock, par value $0.0001 | |
CY2024Q1 | dei |
Trading Symbol
TradingSymbol
|
FOXO | |
CY2024Q1 | dei |
Security Exchange Name
SecurityExchangeName
|
NYSEAMER | |
CY2024Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2024Q1 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2024Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2024Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2024Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2024Q1 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2024Q1 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2024Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
11280154 | shares |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
3000 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
38000 | usd |
CY2024Q1 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
155000 | usd |
CY2023Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
86000 | usd |
CY2024Q1 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
104000 | usd |
CY2023Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
109000 | usd |
CY2024Q1 | us-gaap |
Assets Current
AssetsCurrent
|
262000 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
233000 | usd |
CY2024Q1 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
2621000 | usd |
CY2023Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
378000 | usd |
CY2024Q1 | us-gaap |
Other Assets
OtherAssets
|
111000 | usd |
CY2023Q4 | us-gaap |
Other Assets
OtherAssets
|
114000 | usd |
CY2024Q1 | us-gaap |
Assets
Assets
|
2994000 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
725000 | usd |
CY2024Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
4988000 | usd |
CY2023Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
4556000 | usd |
CY2024Q1 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
386000 | usd |
CY2024Q1 | foxo |
Senior Paid In Kind Notes
SeniorPaidInKindNotes
|
4461000 | usd |
CY2023Q4 | foxo |
Senior Paid In Kind Notes
SeniorPaidInKindNotes
|
4203000 | usd |
CY2024Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1815000 | usd |
CY2023Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1696000 | usd |
CY2024Q1 | foxo |
Accrued Settlement
AccruedSettlement
|
2260000 | usd |
CY2023Q4 | foxo |
Accrued Settlement
AccruedSettlement
|
2260000 | usd |
CY2024Q1 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
42000 | usd |
CY2023Q4 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
30000 | usd |
CY2024Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
17072000 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
14336000 | usd |
CY2023Q4 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
8000 | usd |
CY2024Q1 | us-gaap |
Other Liabilities
OtherLiabilities
|
359000 | usd |
CY2023Q4 | us-gaap |
Other Liabilities
OtherLiabilities
|
481000 | usd |
CY2024Q1 | us-gaap |
Liabilities
Liabilities
|
17931000 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
14825000 | usd |
CY2024Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2024Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
1000 | usd |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
1000 | usd |
CY2024Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
164282000 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
162959000 | usd |
CY2024Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-179220000 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-177060000 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-14937000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-14100000 | usd |
CY2024Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
2994000 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
725000 | usd |
CY2024Q1 | us-gaap |
Revenues
Revenues
|
7000 | usd |
CY2023Q1 | us-gaap |
Revenues
Revenues
|
13000 | usd |
CY2024Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
165000 | usd |
CY2023Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
309000 | usd |
CY2024Q1 | foxo |
Management Contingent Share Plans
ManagementContingentSharePlans
|
33000 | usd |
CY2023Q1 | foxo |
Management Contingent Share Plans
ManagementContingentSharePlans
|
764000 | usd |
CY2024Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
988000 | usd |
CY2023Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
6332000 | usd |
CY2024Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
1186000 | usd |
CY2023Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
7405000 | usd |
CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1179000 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-7392000 | usd |
CY2024Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-8000 | usd |
CY2024Q1 | us-gaap |
Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
|
301000 | usd |
CY2023Q1 | us-gaap |
Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
|
225000 | usd |
CY2024Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-32000 | usd |
CY2023Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-22000 | usd |
CY2024Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-325000 | usd |
CY2023Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-247000 | usd |
CY2024Q1 | us-gaap |
Income Loss Attributable To Parent
IncomeLossAttributableToParent
|
-1504000 | usd |
CY2023Q1 | us-gaap |
Income Loss Attributable To Parent
IncomeLossAttributableToParent
|
-7639000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1504000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7639000 | usd |
CY2024Q1 | foxo |
Deemed Dividend From Trigger Of Down Round Provisions And Extension Of Assumed Warrants
DeemedDividendFromTriggerOfDownRoundProvisionsAndExtensionOfAssumedWarrants
|
656000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-2160000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-7639000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
6708000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-7639000 | usd |
CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
901000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-30000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-14100000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-2160000 | usd |
CY2024Q1 | us-gaap |
Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
|
656000 | usd |
CY2024Q1 | foxo |
Shares Issued Under Kr8 License Agreement Value
SharesIssuedUnderKR8LicenseAgreementValue
|
378000 | usd |
CY2024Q1 | foxo |
Stock Issued During Period Value Share Issued Under Corporate Development And Advisory Agreement
StockIssuedDuringPeriodValueShareIssuedUnderCorporateDevelopmentAndAdvisoryAgreement
|
153000 | usd |
CY2024Q1 | foxo |
Stock Issued During Period Value Warrants Issued For Finders Fees
StockIssuedDuringPeriodValueWarrantsIssuedForFindersFees
|
17000 | usd |
CY2024Q1 | us-gaap |
Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
|
16000 | usd |
CY2024Q1 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
103000 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-14937000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1504000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7639000 | usd |
CY2024Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
260000 | usd |
CY2023Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
929000 | usd |
CY2024Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
119000 | usd |
CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
901000 | usd |
CY2024Q1 | foxo |
Amortization Of Consulting Fees Paid In Common Stock
AmortizationOfConsultingFeesPaidInCommonStock
|
25000 | usd |
CY2023Q1 | foxo |
Amortization Of Consulting Fees Paid In Common Stock
AmortizationOfConsultingFeesPaidInCommonStock
|
1725000 | usd |
CY2024Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-8000 | usd |
CY2024Q1 | us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
258000 | usd |
CY2023Q1 | us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
135000 | usd |
CY2024Q1 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
33000 | usd |
CY2023Q1 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
94000 | usd |
CY2023Q1 | us-gaap |
Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
|
6000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Materials And Supplies
IncreaseDecreaseInMaterialsAndSupplies
|
-11000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-59000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-925000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-5000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-7000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
983000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-489000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
1486000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
35000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
1716000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3360000 | usd |
CY2024Q1 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
2122000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-2122000 | usd |
CY2024Q1 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
371000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
371000 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-35000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-3360000 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
38000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
5515000 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
3000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2155000 | usd |
CY2024Q1 | us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
378000 | usd |
CY2024Q1 | foxo |
Warrants Issued For Finders Fee In Connection Promissory Notes
WarrantsIssuedForFindersFeeInConnectionPromissoryNotes
|
17000 | usd |
CY2024Q1 | foxo |
Deemed Dividend From Trigger Of Down Round Provisions And Extension Of Assumed Warrant
DeemedDividendFromTriggerOfDownRoundProvisionsAndExtensionOfAssumedWarrant
|
656000 | usd |
CY2024Q1 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45.35pt; text-align: justify; text-indent: -45.35pt"><b><span style="text-decoration:underline">Note 1 DESCRIPTION OF BUSINESS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">FOXO Technologies Inc. (“FOXO” or the “Company”), formerly known as Delwinds Insurance Acquisition Corp. (“Delwinds”), a Delaware corporation, was originally formed in April 2020 as a publicly traded special purpose company for the purpose of effecting a merger, capital stock exchange, asset acquisition, reorganization, or similar business combination involving one or more businesses. FOXO is commercializing epigenetic biomarker technology to support groundbreaking scientific research and disruptive next-generation business initiatives. The Company applies automated machine learning and artificial intelligence (“AI”) technologies to discover epigenetic biomarkers of human health, wellness and aging. On October 29, 2023, the Company entered into a Letter Agreement with KR8 AI Inc., a Nevada corporation (“KR8” or the “Licensor”), to develop a Direct-to-Consumer app (iOS and Android) combining its AI Machine Learning technology to provide a commercial application of FOXO’s epigenetic biomarker technology as a subscription consumer engagement platform. In January 2024, the Letter Agreement was replaced by a definitive license agreement, which is more fully discussed in Note 6.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Segments</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company manages and classifies its business into two reportable business segments, FOXO Labs and FOXO Life. While the Company has decided to pause sales of new life insurance products, it still intends to continue to classify its business into the two reportable business segments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The Business Combination</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 24, 2022, Delwinds entered into a definitive Agreement and Plan of Merger, dated as of February 24, 2022, as amended on April 26, 2022, July 6, 2022 and August 12, 2022 (the “Merger Agreement”), with FOXO Technologies Inc., now known as FOXO Technologies Operating Company (“FOXO Technologies Operating Company”), DWIN Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Delwinds (“Merger Sub”), and DIAC Sponsor LLC (the “Sponsor”), in its capacity as the representative of the stockholders of Delwinds from and after the closing (the “Closing”) of the transactions contemplated by the FOXO Transaction Agreement (collectively, the “Transaction” or the “Business Combination”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Business Combination was approved by Delwinds’ stockholders on September 14, 2022, and closed on September 15, 2022 (the “Closing Date”) whereby Merger Sub merged into FOXO Technologies Operating Company, with FOXO Technologies Operating Company surviving the merger as a wholly owned subsidiary of the Company (the “Combined Company”), and with FOXO Technologies Operating Company security holders becoming security holders of the Combined Company. Immediately upon the Closing, the name of Delwinds was changed to FOXO Technologies Inc.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following the Closing, FOXO is a holding company whose wholly-owned subsidiary, FOXO Technologies Operating Company, conducts all of the core business operations. FOXO Technologies Operating Company maintains its two wholly-owned subsidiaries, FOXO Labs Inc. and FOXO Life, LLC. FOXO Labs maintains a wholly-owned subsidiary, Scientific Testing Partners, LLC, while FOXO Life Insurance Company was a wholly-owned subsidiary of FOXO Life, LLC. On February 3, 2023, the Company sold FOXO Life Insurance Company as more fully discussed in Note 9.</p> | |
CY2024Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-2160000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-7639000 | usd |
CY2024Q1 | foxo |
Working Capital Deficit
WorkingCapitalDeficit
|
16810000 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-14937000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
1716000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3360000 | usd |
CY2024Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
3000 | usd |
CY2024Q1 | foxo |
Delinquent Amount Paid
DelinquentAmountPaid
|
65000000 | usd |
CY2024Q1 | foxo |
Delinquent Amount Owes
DelinquentAmountOwes
|
146000000 | usd |
CY2024Q1 | us-gaap |
Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
|
256000 | usd |
CY2024Q1 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
1339000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
1-for-10 reverse stock split | |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
471000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
214000 | usd |
CY2024Q1 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
2621000 | usd |
CY2023Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
378000 | usd |
CY2023Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
257000 | usd |
CY2024Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
922000 | usd |
CY2023Q2 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
2633000 | usd |
CY2022Q3 | us-gaap |
Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
|
2918000 | usd |
CY2022Q3 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
540000 | usd |
CY2024Q1 | foxo |
Paid In Kind Interest Rate
PaidInKindInterestRate
|
0.0115 | pure |
CY2024Q1 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
20000000 | usd |
CY2024Q1 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
2000000 | usd |
CY2024Q1 | foxo |
Pik Note Amendment
PIKNoteAmendment
|
1339000 | usd |
CY2024Q1 | us-gaap |
Percentage Of Unamortized Film Costs
PercentageOfUnamortizedFilmCosts
|
0.10 | pure |
CY2024Q1 | us-gaap |
Other Expenses
OtherExpenses
|
1596000 | usd |
CY2024Q1 | us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
258000 | usd |
CY2023Q1 | us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
135000 | usd |
CY2024Q1 | foxo |
Future Purchase Notices Percentage
FuturePurchaseNoticesPercentage
|
0.10 | pure |
CY2023Q4 | foxo |
Gross Proceeds Percentage
GrossProceedsPercentage
|
0.03 | pure |
CY2023Q4 | us-gaap |
Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
|
P5Y | |
CY2023Q4 | foxo |
Percentage Of Warrant Coverage
PercentageOfWarrantCoverage
|
1.10 | pure |
CY2024Q1 | us-gaap |
Proceeds From Fees Received
ProceedsFromFeesReceived
|
371000 | usd |
CY2024Q1 | us-gaap |
Interest Expense
InterestExpense
|
42000 | usd |
CY2024Q1 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
33000 | usd |
CY2024Q1 | us-gaap |
Payments For Fees
PaymentsForFees
|
17000 | usd |
CY2024Q1 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
386000 | usd |
CY2024Q1 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
196000 | usd |
CY2023Q1 | us-gaap |
Costs And Expenses Related Party
CostsAndExpensesRelatedParty
|
2018000 | usd |
CY2024Q1 | foxo |
Development Fee
DevelopmentFee
|
2500000 | usd |
CY2024Q1 | us-gaap |
Cost Maintenance
CostMaintenance
|
50000 | usd |
CY2024Q1 | foxo |
Subscriber Revenuess Percentage
SubscriberRevenuessPercentage
|
0.15 | pure |
CY2024Q1 | foxo |
Minimum Royalties
MinimumRoyalties
|
100000 | usd |
CY2024Q1 | foxo |
Accrued Initial License And Development Fees
AccruedInitialLicenseAndDevelopmentFees
|
2623000 | usd |
CY2024Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2024Q1 | foxo |
Outstanding Balance Percentage
OutstandingBalancePercentage
|
0.0999 | pure |
CY2024Q1 | foxo |
Percentage Of Exercise Price
PercentageOfExercisePrice
|
1.10 | pure |
CY2024Q1 | foxo |
Percentage Of Cash Fee
PercentageOfCashFee
|
0.03 | pure |
CY2024Q1 | foxo |
Percentage Of Warrant Coverage For Equity Transaction
PercentageOfWarrantCoverageForEquityTransaction
|
0.07 | pure |
CY2023Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
234000 | usd |
CY2023Q3 | foxo |
Rights Shares Issued
RightsSharesIssued
|
511026 | shares |
CY2023Q3 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
409000 | shares |
CY2024Q1 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
25672 | shares |
CY2024Q1 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
598877 | shares |
CY2024Q1 | us-gaap |
Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable
ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
|
2024-02-24 | |
CY2024Q1 | foxo |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Exerciable
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExerciable
|
3315227 | shares |
CY2024Q1 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.34 | |
CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P1Y | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
|
0 | usd |
CY2023Q2 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
25868 | shares |
CY2024Q1 | us-gaap |
Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
|
15001 | shares |
CY2023Q1 | us-gaap |
Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
|
423700 | shares |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1504000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7639000 | usd |
CY2024Q1 | foxo |
Deemed Dividends Related To Assumed Warrants
DeemedDividendsRelatedToAssumedWarrants
|
-656000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-2160000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-7639000 | usd |
CY2023 | us-gaap |
Severance Costs1
SeveranceCosts1
|
1575000 | usd |
CY2023Q1 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Severance Payments
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSeverancePayments
|
462000 | usd |
CY2024Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4540732 | shares |
CY2023Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
1455770 | shares |
CY2023Q1 | us-gaap |
Statutory Accounting Practices Statutory Capital And Surplus Required
StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired
|
5002000 | usd |
CY2023Q1 | us-gaap |
Payments For Merger Related Costs
PaymentsForMergerRelatedCosts
|
200000 | usd |
CY2023Q1 | us-gaap |
Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
|
251000 | usd |
CY2024Q1 | foxo |
Merger Consideration And Buyers Third Party Expenses Transaction Gain
MergerConsiderationAndBuyersThirdPartyExpensesTransactionGain
|
4751000 | usd |
CY2024Q1 | us-gaap |
Revenues
Revenues
|
7000 | usd |
CY2023Q1 | us-gaap |
Revenues
Revenues
|
13000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1504000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7639000 | usd |
CY2024Q1 | foxo |
Amortization Of Consulting Fees
AmortizationOfConsultingFees
|
144000 | usd |
CY2024Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
260000 | usd |
CY2023Q1 | foxo |
Consulting Agreement Expense
ConsultingAgreementExpense
|
2626000 | usd |
CY2023Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
929000 | usd |
CY2024Q1 | us-gaap |
Proceeds From Legal Settlements
ProceedsFromLegalSettlements
|
2260000 | usd |
CY2023 | us-gaap |
Proceeds From Legal Settlements
ProceedsFromLegalSettlements
|
2260000 | usd |
CY2022Q4 | us-gaap |
Loss Contingency Damages Paid Value
LossContingencyDamagesPaidValue
|
6207000 | usd |
CY2024Q1 | foxo |
Percentage Of Gross Proceeds
PercentageOfGrossProceeds
|
0.25 | pure |
CY2024Q1 | us-gaap |
Payments For Legal Settlements
PaymentsForLegalSettlements
|
300000 | usd |
CY2024Q1 | us-gaap |
Accelerated Share Repurchases Settlement Payment Or Receipt
AcceleratedShareRepurchasesSettlementPaymentOrReceipt
|
50000 | usd |
CY2024Q1 | foxo |
Revenues Received Percentage
RevenuesReceivedPercentage
|
0.15 | pure |
CY2024Q2 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
312500 | shares |
CY2024Q1 | us-gaap |
Severance Costs1
SeveranceCosts1
|
1575000 | usd |
CY2024Q1 | foxo |
Purchase Of Securities
PurchaseOfSecurities
|
840000 | usd |
CY2024Q1 | foxo |
Purchases Of Securities Shares
PurchasesOfSecuritiesShares
|
1108755 | shares |
CY2024Q1 | us-gaap |
Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
|
280000 | usd |
CY2024Q1 | foxo |
Senior Notes Principal Amount
SeniorNotesPrincipalAmount
|
1120000 | usd |
CY2024Q1 | foxo |
Accrued Interest Percentage
AccruedInterestPercentage
|
0.18 | pure |
CY2024Q1 | foxo |
Percentage Of Prepayment
PercentageOfPrepayment
|
1 | pure |
CY2024Q1 | us-gaap |
Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
|
179000 | usd |
CY2023Q1 | us-gaap |
Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
|
13000 | usd |
CY2024Q1 | us-gaap |
Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
|
-2069000 | usd |
CY2023Q1 | us-gaap |
Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
|
-7738000 | usd |
CY2024Q1 | us-gaap |
Dividends Common Stock
DividendsCommonStock
|
656000 | usd |
CY2024Q1 | foxo |
Business Acquisitions Pro Forma Net Loss To Common Stockholders
BusinessAcquisitionsProFormaNetLossToCommonStockholders
|
-2725000 | usd |
CY2023Q1 | foxo |
Business Acquisitions Pro Forma Net Loss To Common Stockholders
BusinessAcquisitionsProFormaNetLossToCommonStockholders
|
-7738000 | usd |
CY2024Q1 | us-gaap |
Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
|
-0.23 | |
CY2023Q1 | us-gaap |
Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
|
-1.5 | |
CY2024Q1 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2024Q1 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2024Q1 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false | |
CY2024Q1 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2024Q1 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
usd | |
CY2023Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2024Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2023Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2024Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
shares | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
shares | |
CY2024Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
shares | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
shares | |
CY2023Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
usd | |
CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2023Q1 | foxo |
Deemed Dividend From Trigger Of Down Round Provisions And Extension Of Assumed Warrants
DeemedDividendFromTriggerOfDownRoundProvisionsAndExtensionOfAssumedWarrants
|
usd | |
CY2024Q1 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
usd | |
CY2023Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
usd | |
CY2024Q1 | us-gaap |
Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
|
usd | |
CY2024Q1 | us-gaap |
Increase Decrease In Materials And Supplies
IncreaseDecreaseInMaterialsAndSupplies
|
usd | |
CY2023Q1 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
usd | |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | |
CY2023Q1 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
usd | |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
usd | |
CY2023Q1 | us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
usd | |
CY2023Q1 | foxo |
Warrants Issued For Finders Fee In Connection Promissory Notes
WarrantsIssuedForFindersFeeInConnectionPromissoryNotes
|
usd | |
CY2023Q1 | foxo |
Deemed Dividend From Trigger Of Down Round Provisions And Extension Of Assumed Warrant
DeemedDividendFromTriggerOfDownRoundProvisionsAndExtensionOfAssumedWarrant
|
usd | |
CY2024Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
usd | |
CY2023Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
usd | |
CY2024Q1 | us-gaap |
Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
|
P5Y | |
CY2024Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
shares | |
CY2024Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
shares | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
shares | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
shares | |
CY2023Q1 | foxo |
Deemed Dividends Related To Assumed Warrants
DeemedDividendsRelatedToAssumedWarrants
|
usd | |
CY2023Q1 | us-gaap |
Dividends Common Stock
DividendsCommonStock
|
usd | |
CY2024Q1 | us-gaap |
Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
|
-0.23 | |
CY2023Q1 | us-gaap |
Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
|
-1.50 | |
CY2024Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2024Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2024Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2024Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001812360 |